Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical Stem Cell Transplantation in Children With Non-Malignant Hematological Disorders
NCT04356469Phase 2Recruiting
- Sponsor
- Johns Hopkins All Children's Hospital
- Start
- Jul 2020
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in hemoglobinopathy, aplastic anemia and bone marrow failure syndrome (BMFS), sponsored by Johns Hopkins All Children's Hospital. Primary endpoint: Incidence of successful donor engraftment at Day 100. Started Jul 2020; status: recruiting.
02
Conditions
hemoglobinopathyaplastic anemiabone marrow failure syndrome (BMFS)
Beyond the preview
Go deeper on NCT04356469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356469.